Summaries from the American Academy of Allergy Asthma & Immunology Annual Meeting, held from February 24 – 27, 2023.
Atopic dermatitis: researchers quantify risk of heavy traffic, question drug safety restrictions, and more
Presenters: Michael Z. Nevid, MD; Alexandro Chu, BHSc
The contribution of high-traffic roads to atopic dermatitis and the association of cancer with pimecrolimus and tacrolimus are featured among the studies presented in this session.
Asthma in elderly patients: community assistance, depression, and cognitive dysfunction
Presenters: Andrea J. Apter, MD, MA, MSc; Paula J. Busse, MD; Nizar N. Jarjour, MD
Concerns for elderly patients with asthma include the potential benefit of community assistance, the consequences of depression, and increased risk of cognitive dysfunction.
Drug allergy expertise improves care in other specialties
Presenters: Anna R. Wolfson, MD; Tanya M. Laidlaw, MD; Aleena Banerji, MD
Drug allergies impact patient care across most specialties.
Managing anaphylaxis: risk management and clear communication
Presenters: Marcus Shaker, MD, MS; Karla E. Adams, MD; and Gerald Volcheck, MD
Speakers consider controversial aspects of biphasic anaphylaxis, offer perspectives on venom immunotherapy, and discuss prevention of perioperative anaphylaxis.
Global climate change parallels health risks
Presenters: Rachel L. Miller, MD; Lisa A. Miller, PhD; and Cezmi Akdis, MD
Climate and environmental changes are outpacing the evolution of the human immune system.
Eosinophilic esophagitis: promising therapy, biomarkers, and assessment tools
Presenters: Evan S. Dellon, MD, MPH; Justin Schwartz, MD, PhD; and Seema S. Aceves, MD, PhD
New diagnostic, monitoring, and treatment approaches are available for eosinophilic gastrointestinal diseases, including breakthroughs in eosinophilic esophagitis with new biologics and biomarkers.